An observational study of the epidermal growth factor receptor-tyrosine kinase inhibitor resistance mechanism in epidermal growth factor receptor gene mutation-positive non-small cell lung cancer. [electronic resource]
Producer: 20181023Description: e12660 p. digitalISSN:- 1536-5964
- Afatinib
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Disease-Free Survival
- Drug Resistance, Neoplasm -- drug effects
- ErbB Receptors -- genetics
- Gefitinib
- Humans
- Lung Neoplasms -- drug therapy
- Prospective Studies
- Protein Kinase Inhibitors -- pharmacology
- Proteomics
- Quinazolines -- pharmacology
- Research Design
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Observational Study
There are no comments on this title.
Log in to your account to post a comment.